Jul 2026
Cycloastragenol overcomes trastuzumab resistance in HER2-positive breast cancer by regulating cell cycle and epithelial-mesenchymal transition through EZH2/PTEN/AKT pathway.
Mingyuan Wu, Fenggang Hou, Zhaoshuo Yang et al.
· Naunyn-Schmiedeberg's Archiv... · 0 citations